Shopping Cart 0
Cart Subtotal
USD 0

Oncgnostics GmbH-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company's pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the methylation of specific DNA regions. Its GynTect allows a fast and reliable detection of cervical precancerous lesions and cancer. The company's pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors. It also specializes in the IVD test development field at, after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Oncgnostics GmbH

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Oncgnostics GmbH Company Overview 4

Oncgnostics GmbH Company Snapshot 4

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Oncgnostics GmbH-Pipeline Analysis Overview 7

Oncgnostics GmbH-Key Facts 7

Oncgnostics GmbH-Major Products and Services 8

Oncgnostics GmbH Pipeline Products by Development Stage 9

Oncgnostics GmbH Pipeline Products Overview 11

GynTect 11

GynTect Product Overview 11

GynTect 2.0 12

GynTect 2.0 Product Overview 12

Oncgnostics Diagnostic Test-Head & Neck Cancer 13

Oncgnostics Diagnostic Test-Head & Neck Cancer Product Overview 13

Oncgnostics Diagnostic Test-Ovarian Cancer 14

Oncgnostics Diagnostic Test-Ovarian Cancer Product Overview 14

Oncgnostics GmbH-Key Competitors 15

Oncgnostics GmbH-Key Employees 16

Oncgnostics GmbH-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Oncgnostics GmbH, Recent Developments 18

Sep 20, 2016: Early Detection of Ervical cancer: " GynTect 2.0"- Wider Range of Application by Using a Greater Variety of Patient Samples 18

Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India 18

Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive 19

Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect" 19

Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014 20

Appendix 21

Methodology 21

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Oncgnostics GmbH Pipeline Products by Equipment Type 5

Oncgnostics GmbH Pipeline Products by Development Stage 9


List Of Table

List of Tables

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Oncgnostics GmbH Pipeline Products by Equipment Type 5

Oncgnostics GmbH Pipeline Products by Indication 6

Oncgnostics GmbH, Key Facts 7

Oncgnostics GmbH, Major Products and Services 8

Oncgnostics GmbH Number of Pipeline Products by Development Stage 9

Oncgnostics GmbH Pipeline Products Summary by Development Stage 10

GynTect-Product Status 11

GynTect-Product Description 11

GynTect 2.0-Product Status 12

GynTect 2.0-Product Description 12

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Status 13

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Description 13

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Status 14

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Description 14

Oncgnostics GmbH, Key Employees 16

Glossary 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Oncgnostics GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Summary

Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company's pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the methylation of specific DNA regions. Its GynTect allows a fast and reliable detection of cervical precancerous lesions and cancer. The company's pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors. It also specializes in the IVD test development field at, after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Oncgnostics GmbH

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Oncgnostics GmbH Company Overview 4

Oncgnostics GmbH Company Snapshot 4

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Oncgnostics GmbH-Pipeline Analysis Overview 7

Oncgnostics GmbH-Key Facts 7

Oncgnostics GmbH-Major Products and Services 8

Oncgnostics GmbH Pipeline Products by Development Stage 9

Oncgnostics GmbH Pipeline Products Overview 11

GynTect 11

GynTect Product Overview 11

GynTect 2.0 12

GynTect 2.0 Product Overview 12

Oncgnostics Diagnostic Test-Head & Neck Cancer 13

Oncgnostics Diagnostic Test-Head & Neck Cancer Product Overview 13

Oncgnostics Diagnostic Test-Ovarian Cancer 14

Oncgnostics Diagnostic Test-Ovarian Cancer Product Overview 14

Oncgnostics GmbH-Key Competitors 15

Oncgnostics GmbH-Key Employees 16

Oncgnostics GmbH-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Oncgnostics GmbH, Recent Developments 18

Sep 20, 2016: Early Detection of Ervical cancer: " GynTect 2.0"- Wider Range of Application by Using a Greater Variety of Patient Samples 18

Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India 18

Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive 19

Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect" 19

Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014 20

Appendix 21

Methodology 21

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Oncgnostics GmbH Pipeline Products by Equipment Type 5

Oncgnostics GmbH Pipeline Products by Development Stage 9


List Of Table

List of Tables

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Oncgnostics GmbH Pipeline Products by Equipment Type 5

Oncgnostics GmbH Pipeline Products by Indication 6

Oncgnostics GmbH, Key Facts 7

Oncgnostics GmbH, Major Products and Services 8

Oncgnostics GmbH Number of Pipeline Products by Development Stage 9

Oncgnostics GmbH Pipeline Products Summary by Development Stage 10

GynTect-Product Status 11

GynTect-Product Description 11

GynTect 2.0-Product Status 12

GynTect 2.0-Product Description 12

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Status 13

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Description 13

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Status 14

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Description 14

Oncgnostics GmbH, Key Employees 16

Glossary 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Oncgnostics GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies